Cassava Sciences, Inc. (SAVA)
1.995
-0.04
(-1.72%)
USD |
NASDAQ |
Dec 31, 12:06
Cassava Sciences Free Cash Flow: -83.91M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| cbdMD, Inc. | -1.636M |
| BioMarin Pharmaceutical, Inc. | 825.79M |
| Amicus Therapeutics, Inc. | 9.691M |
| Geron Corp. | -132.68M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.221M |
| Cash from Investing (Quarterly) | -0.08M |
| Free Cash Flow Per Share (Quarterly) | -0.1304 |
| Free Cash Flow to Equity (Quarterly) | -6.301M |
| Free Cash Flow to Firm (Quarterly) | -6.301M |
| Free Cash Flow Yield | -87.18% |